Catalyst Biosciences, Inc.

NASDAQ:CBIO

16.15 (USD) • At close July 1, 2025
Bedrijfsnaam Catalyst Biosciences, Inc.
Symbool CBIO
Munteenheid USD
Prijs 16.15
Beurswaarde 314,925,000
Dividendpercentage 0%
52-weken bereik 11.06 - 63
Industrie Biotechnology
Sector Healthcare
CEO Dr. Nassim Usman Ph.D.
Website https://www.catalystbiosciences.com

An error occurred while fetching data.

Over Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3)

Vergelijkbare Aandelen

Venus Concept Inc. logo

Venus Concept Inc.

VERO

2.62 USD

Accelerate Diagnostics, Inc. logo

Accelerate Diagnostics, Inc.

AXDX

0.034 USD

Syros Pharmaceuticals, Inc. logo

Syros Pharmaceuticals, Inc.

SYRS

0.023 USD

Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc.

CRVS

3.86 USD

MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc.

INKT

7.34 USD

Greenbrook TMS Inc. logo

Greenbrook TMS Inc.

GBNH

0.121 USD

ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V.

PRQR

2.01 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)